Yahoo

Study Finds the Corus(R) CAD Gene Expression Blood Test Influenced Primary Care Decision-Making in the Assessment of Patients With Suspected Obstructive Coronary Artery Disease

PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...
Yahoo Finance

New Study Results Further Reinforce That the Corus(R) CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions for Patients With Suspected Obstructive Coronary ...

Patients With a Low Corus CAD Score Had 94% Reduced Odds of Referral to a Cardiologist; REGISTRY I Study Results Add to the Established Evidence Base Supporting the Clinical Utility of the Corus CAD ...
FierceBiotech

Study: Corus CAD demonstrates superiority to MPI

CardioDx saw good news from Florida this week with the presentation of results from the COMPASS trial involving Corus CAD, a blood-based gene expression test for obstructive coronary artery disease.
Yahoo Finance

CardioDx Announces Results of Study Demonstrating the Benefits of the Corus CAD Gene Expression Test Use in an African American Patient Population

REDWOOD CITY, CA--(Marketwired - Oct 20, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a ...
News Medical

Clinical study shows association between Corus CAD blood test scores and cardiovascular event rates

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a genomic substudy of the NHLBI-funded Prospective Multicenter Imaging Study for ...
FierceBiotech

CardioDx extols virtues of CAD test in new study

It's been a difficult year for CardioDx, but there may be light at the end of the tunnel: In a new study, researchers found that the company's genetic test for coronary artery disease could help ...